Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease

IMPORTANCE: Targeted therapies have been hypothesized to prolong survival in the treatment of patients with intracranial metastatic disease (IMD) but, paradoxically, increase IMD incidence by improving systemic disease control and prolonging survival from the primary tumor. The real-world benefits o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Erickson, Anders W., Habbous, Steven, Wright, Frances, Lofters, Aisha K., Jerzak, Katarzyna J., Das, Sunit
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176387/
https://ncbi.nlm.nih.gov/pubmed/34081080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.1600
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados